• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 13-11-2025: Press Release

    13-11-2025 | 01:54 pm

    Zydus has received final USFDA approval for Diroximel Fumarate delayed-release capsules, 231 mg. This opens access to the US multiple sclerosis market, which has annual sales of USD 999.4 mn. A key portfolio booster.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited